UC Davis Health molecular exercise physiologist Keith Baar specializes in sports medicine. He studies the effects of exercise ...
Morgan Stanley (NYSE:MS) reiterated its Overweight rating and $330.00 price target on Workday (NASDAQ:WDAY), a prominent player in the software industry with a market capitalization of $72.85 billion, ...
Alphabet analysts see strength in the company's search and YouTube business segments, while questions around cloud and increased spending remain.
As of the latest trading close, CDMO, a Healthcare sector stock, is trading -0.04% below its 52-week high but remains 111.69% above its 52-week low. The Average True Range (ATR) (14 days) of 0.06 ...
Piper Sandler upgraded Simon Property Group (NYSE:SPG) to Overweight from Neutral as the shopping mall REIT's 2025 outlook highlights the underlying earnings power of its real estate portfolio. The ...
The FTSE World Government Bond Index (“WGBI”) measures the performance of fixed-rate, local-currency, investment-grade ...
Novo Nordisk has a dominant position in diabetes and weight-loss drugs, strong financial growth outlook, and great potential. Click to read why NVO is a Strong Buy.
Doncic and Maxi Kleber were traded from the Mavs to the Lakers for Anthony Davis, Max Christie and the 2029 first-round pick. The new Lakers star is already a very wealthy man. He's in the middle of a ...
A colorectal surgeon named Dr Cedrek McFadden has shared the top five reasons why people may be at risk of getting colorectal ...
Morgan Stanley lowered the firm’s price target on Ball Corp. (BALL) to $70 from $75 and keeps an Overweight rating on the shares. Ball shares ...
ETH Zurich researchers collected cells from overweight individuals to identify biological markers that raise the risk of metabolic diseases.
AbbVie (NYSE:ABBV – Get Free Report) had its target price raised by equities research analysts at Wells Fargo & Company from $195.00 to $210.00 in a note issued to investors on Monday,Benzinga reports ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results